Peripheral Blood Stem Cell TransplantationStem CellsHematopoietic Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem CellsHematopoietic Stem Cell MobilizationBone MarrowBone Marrow TransplantationBone Marrow CellsAdult Stem CellsGranulocyte Colony-Stimulating FactorLeukapheresisEmbryonic Stem CellsTransplantation, HomologousBlood Component RemovalAntigens, CD34Stem Cell TransplantationTransplantation ConditioningCell DifferentiationHematologic NeoplasmsGraft vs Host DiseaseMelphalanCord Blood Stem Cell TransplantationCyclophosphamideCombined Modality TherapyGraft SurvivalMultiple MyelomaHematopoiesisBlood CellsBusulfanAntineoplastic Combined Chemotherapy ProtocolsBone Marrow DiseasesBlood Cell CountPluripotent Stem CellsBone and BonesTreatment OutcomeStem Cell NicheBone Marrow PurgingTissue DonorsLymphoma, Non-HodgkinStem Cell FactorEtoposideTransplantation ChimeraWhole-Body IrradiationColony-Forming Units AssayAntineoplastic Agents, AlkylatingMyeloablative AgonistsRecurrenceThiotepaNeural Stem CellsInduced Pluripotent Stem CellsCells, CulturedMesenchymal Stem Cell TransplantationCell SeparationRemission InductionFlow CytometryHistocompatibilityMultipotent Stem CellsLeukemiaMesenchymal Stromal CellsCell LineageTime FactorsHistocompatibility TestingPlatelet CountAnemia, AplasticImmunophenotypingBlood DonorsIfosfamideCytarabineFetal BloodDisease-Free SurvivalLeukemia, Myeloid, AcuteInfectionRecombinant ProteinsAntigens, CDLeukocyte CountTransplantation, IsogeneicVidarabineImmunomagnetic SeparationSalvage TherapyVincristineRetrospective StudiesSurvival RateBone Marrow ExaminationPOEMS SyndromeImmunosuppressive AgentsMice, Inbred C57BLHodgkin DiseaseLymphomaLeukemia, Myelogenous, Chronic, BCR-ABL PositiveNeoplasmsSurvival AnalysisHematologic DiseasesMyelodysplastic SyndromesBone Marrow NeoplasmsCell CountGranulocytesLeukocytes, MononuclearT-LymphocytesCell Proliferation